Research article · 4 Sep 2025
CommentaryPublished 29 Sep 2021
COVID-19 Vaccine Allergies are Rare, Typically Mild and Treatable
Keywords
Subjects
Pharmaceutical SciencesSimilar by topic
Opinion · 3 Mar 2025
COVID-19 Vaccinations Monitored for Safety and Effectiveness
Editorial · 27 Feb 2025
Advances in mRNA Therapeutics: From COVID-19 Vaccines to Cancer Treatment
Perspective · 28 Jun 2023
Guillain-Barré Syndrome (GBS) and COVID-19 Vaccination in Individuals Aged 50 and Above
Review article · 20 Feb 2023
Generalized Morphea after COVID-19 Vaccination along with Characteristic Nature of Spike Protein
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Joshua Ikoni Ogaji”

